4731 – 4740 of 7621
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Subsequent cancers in patients diagnosed with cancer of unknown primary (CUP): etiological insights?
(
- Contribution to journal › Article
-
Mark
Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
2012) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 21(4). p.645-657(
- Contribution to journal › Article
-
Mark
Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibition.
(
- Contribution to journal › Article
-
Mark
Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours.
(
- Contribution to journal › Article
-
Mark
Major chromosomal breakpoint intervals in breast cancer co-localize with differentially methylated regions.
(
- Contribution to journal › Article
-
Mark
Retained heterodisomy is associated with high gene expression in hyperhaploid inflammatory leiomyosarcoma.
(
- Contribution to journal › Article
-
Mark
Increased gene copy number of KIT and VEGFR2 at 4q12 in primary breast cancer is related to an aggressive phenotype and impaired prognosis.
(
- Contribution to journal › Article
-
Mark
Is Family History Associated With Improved Survival in Patients With Gastric Cancer?
(
- Contribution to journal › Article
-
Mark
Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries.
2012) In International Journal of Cancer(
- Contribution to journal › Article
-
Mark
FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone as First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer.
(
- Contribution to journal › Article